Exact Mass: 545.178
Exact Mass Matches: 545.178
Found 441 metabolites which its exact mass value is equals to given mass value 545.178
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Alvelestat
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C783 - Protease Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Doxorubicinol
Doxorubicinol belongs to the family of Anthracyclines. These are polyketides containing a tetracenequinone ring structure with a sugar attached by glycosidic linkage.
Lacto-N-triaose
Human beta-1,3-N-acetylglucosaminyltransferase 2 (beta3GnT2) converts lacto-N-triose II into lacto-N-tetraose and lacto-N-neotetraose. (PMID:16277601).
Lacto-N-triose I
Lacto-N-triose I is found in milk and milk products. Lacto-N-triose I is isolated from the partial acid hydrolysis of human milk. Isolated from the partial acid hydrolysis of human milk. Lacto-N-triose I is found in milk and milk products.
N-Acetylgalactosaminyl lactose
N-Acetylgalactosaminyl lactose is a trisaccharide obtained from bovine colostrum. A trisaccharide obtained from bovine colostrum
4-{[4-(Diethylamino)phenyl](2,4-disulfophenyl)methylene}-N,N-diethyl-2,5-cyclohexadien-1-iminium
4-{[4-(Diethylamino)phenyl](2,4-disulfophenyl)methylene}-N,N-diethyl-2,5-cyclohexadien-1-iminium belongs to the family of Diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. (http://en.wikipedia.org/wiki/Diphenylmethane)
Doxorubicinol aglycone
Doxorubicinol aglycone is a metabolite of doxorubicin. Doxorubicin is a drug used in cancer chemotherapy. It is an anthracycline antibiotic, closely related to the natural product daunomycin, and like all anthracyclines, it works by intercalating DNA. Doxorubicin is commonly used in the treatment of a wide range of cancers, including hematological malignancies, many types of carcinoma, and soft tissue sarcomas. Doxorubicins most serious adverse effect is life-threatening heart damage. (Wikipedia)
alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc
Alvelestat
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C783 - Protease Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Gal-alpha1,4Gal-beta1,4-GlcNAc
THOS Streptonigrin
Adafosbuvir
6-O-[2-Acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-b-D-glucopyranosyl]-D-galactopyranose
O3-(2-acetylamino-O3-beta-D-galactopyranosyl-2-deoxy-beta-D-glucopyranosyl)-D-galactose|O3-(2-Acetylamino-O3-beta-D-galactopyranosyl-2-desoxy-beta-D-glucopyranosyl)-D-galactose
N-Ac-2-Amino-2-deoxy-beta-D-glucopyranosyl-(1?3)-beta-D-galactopyranosyl-(1?4)-D-glucose
His Phe Gln Asp
Gln Phe His Asp
Cys Phe Asn Tyr
Cys Phe Tyr Asn
Cys His Met Arg
Cys His Arg Met
Cys His Thr Trp
Cys His Trp Thr
Cys Met His Arg
Cys Met Arg His
Cys Asn Phe Tyr
Cys Asn Tyr Phe
Cys Arg His Met
Cys Arg Met His
Cys Thr His Trp
Cys Thr Trp His
Cys Trp His Thr
Cys Trp Thr His
Cys Tyr Phe Asn
Cys Tyr Asn Phe
Asp Glu Pro Trp
Asp Glu Trp Pro
Asp Phe His Gln
Asp Phe Gln His
Asp His Phe Gln
Asp His Gln Phe
Asp Pro Glu Trp
Asp Pro Trp Glu
Asp Gln Phe His
Asp Gln His Phe
Asp Trp Glu Pro
Asp Trp Pro Glu
Glu Asp Pro Trp
Glu Asp Trp Pro
Glu Phe His Asn
Glu Phe Asn His
Glu His Phe Asn
Glu His Asn Phe
Glu Asn Phe His
Glu Asn His Phe
Glu Pro Asp Trp
Glu Pro Trp Asp
Glu Trp Asp Pro
Glu Trp Pro Asp
Phe Cys Asn Tyr
Phe Cys Tyr Asn
Phe Asp His Gln
Phe Asp Gln His
Phe Glu His Asn
Phe Glu Asn His
Phe His Asp Gln
Phe His Glu Asn
Phe His Asn Glu
Phe His Gln Asp
Phe Asn Cys Tyr
Phe Asn Glu His
Phe Asn His Glu
Phe Asn Tyr Cys
Phe Gln Asp His
Phe Gln His Asp
Phe Tyr Cys Asn
Phe Tyr Asn Cys
His Cys Met Arg
His Cys Arg Met
His Cys Thr Trp
His Cys Trp Thr
His Asp Phe Gln
His Asp Gln Phe
His Glu Phe Asn
His Glu Asn Phe
His Phe Asp Gln
His Phe Glu Asn
His Phe Asn Glu
His Met Cys Arg
His Met Met Gln
His Met Gln Met
His Met Arg Cys
His Asn Glu Phe
His Asn Phe Glu
His Gln Asp Phe
His Gln Phe Asp
His Gln Met Met
His Arg Cys Met
His Arg Met Cys
His Thr Cys Trp
His Thr Trp Cys
His Trp Cys Thr
His Trp Thr Cys
Met Cys His Arg
Met Cys Arg His
Met His Cys Arg
Met His Met Gln
Met His Gln Met
Met His Arg Cys
Met Met His Gln
Met Met Gln His
Met Gln His Met
Met Gln Met His
Met Arg Cys His
Met Arg His Cys
Asn Cys Phe Tyr
Asn Cys Tyr Phe
Asn Glu Phe His
Asn Glu His Phe
Asn Phe Cys Tyr
Asn Phe Glu His
Asn Phe His Glu
Asn Phe Tyr Cys
Asn His Glu Phe
Asn His Phe Glu
Asn Ser Tyr Tyr
Asn Tyr Cys Phe
Asn Tyr Phe Cys
Asn Tyr Ser Tyr
Asn Tyr Tyr Ser
Pro Asp Glu Trp
Pro Asp Trp Glu
Pro Glu Asp Trp
Pro Glu Trp Asp
Pro Trp Asp Glu
Pro Trp Glu Asp
Gln Asp Phe His
Gln Asp His Phe
Gln Phe Asp His
Gln His Asp Phe
Gln His Phe Asp
Gln His Met Met
Gln Met His Met
Gln Met Met His
Arg Cys His Met
Arg Cys Met His
Arg His Cys Met
Arg His Met Cys
Arg Met Cys His
Arg Met His Cys
Ser Asn Tyr Tyr
Ser Tyr Asn Tyr
Ser Tyr Tyr Asn
Thr Cys His Trp
Thr Cys Trp His
Thr His Cys Trp
Thr His Trp Cys
Thr Trp Cys His
Thr Trp His Cys
Trp Cys His Thr
Trp Cys Thr His
Trp Asp Glu Pro
Trp Asp Pro Glu
Trp Glu Asp Pro
Trp Glu Pro Asp
Trp His Cys Thr
Trp His Thr Cys
Trp Pro Asp Glu
Trp Pro Glu Asp
Trp Thr Cys His
Trp Thr His Cys
Tyr Cys Phe Asn
Tyr Cys Asn Phe
Tyr Phe Cys Asn
Tyr Phe Asn Cys
Tyr Asn Cys Phe
Tyr Asn Phe Cys
Tyr Asn Ser Tyr
Tyr Asn Tyr Ser
Tyr Ser Asn Tyr
Tyr Ser Tyr Asn
Tyr Tyr Asn Ser
Tyr Tyr Ser Asn
Lacto-N-triaose
Doxorubicinol
A member of the class of tetracenequinones that is the major metabolite of the anthracycline doxorubicin, a chemotherapeutic agent effective against a broad range of malignant neoplasms. It is thought to exhibit cardiotoxic properties.
Lacto-N-triose I
N-Acetylgalactosaminyl lactose
2-nitrophenyl-beta-d-galactopyranoside-6-phosphate dicyclohexyl
4-O-(6-O-[2-Acetamido-2-deoxy-b-D-glucopyranosyl]-b-D-galactopyranosyl)-D-glucopyranose
betaLacNAc
Sufrexal
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Ketanserin (R41468) tartrate is a selective 5-HT2 receptor antagonist. Ketanserin tartrate also blocks hERG current (IhERG) in a concentration-dependent manner (IC50=0.11 μM).
3-[(2R)-2-Amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione
4-nitrophenyl 2-acetamido-3-o-(2-acetamido-2-deoxy-b-d-glucopyranosyl)-2-deoxy-a-d-galactopyranoside
4-Nitrophenyl 2-acetamido-6-O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-2-deoxy-α-D-galactopyranoside
Uprifosbuvir
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C25995 - RNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent
O-2-(Acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-alpha-D-galactopyranosyl-(1-4)-D-glucose
Adafosbuvir
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C25995 - RNA Polymerase Inhibitor
Gefapixant citrate
C78272 - Agent Affecting Nervous System > C177180 - P2X Purinoreceptor Antagonist
[4-[[4-(Diethylamino)phenyl]-(2,4-disulfophenyl)methylidene]cyclohexa-2,5-dien-1-ylidene]-diethylazanium
N-[(2S,3R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide
4-{[4-(Diethylamino)phenyl](2,5-disulfophenyl)methylidene}-N,N-diethylcyclohexa-2,5-dien-1-iminium
alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc
alpha-D-galactosyl-(1,3)-beta-D-galactosyl-(1,4)-N-acetyl-D-glucosamine
beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->2)-alpha-D-Manp
N-[(2S,3R,4R,5S,6R)-2-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(2R,3S,4S,5S,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc
alpha-D-Man-(1->3)-beta-D-Man-(1->4)-beta-D-GlcNAc
4-[(2E)-2-[(3-Methyl-1-phenyl-5-pyrrolidin-1-ylpyrazol-4-yl)methylidene]hydrazinyl]-3-nitro-N-phenylbenzenesulfonamide
N-[[(4S,5S)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-(1-piperidinyl)propanamide
N-[[(4S,5R)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-(1-piperidinyl)propanamide
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[(2R,3S,4S,5R,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5S,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4S,5R,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]oxan-3-yl]acetamide
N-acetyl-alpha-D-galactosaminyl-(1->3)-beta-D-galactosyl-(1->4)-D-glucose
beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->6)-D-mannopyranose
alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->4)-N-acetyl-D-glucosamine
beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->6)-beta-D-galactose
beta-D-Glcp-(1->6)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
alpha-D-Gal-(1->4)-beta-D-Gal-(1->3)-alpha-D-GalNAc
beta-D-Galp-(1->4)-beta-D-Glcp-(1->6)-beta-D-GlcpNAc
alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-NHAc
alpha-D-Gal-(1->3)-beta-D-Gal-(1->3)-beta-D-GlcNAc
(3R,3R,4S,6R,8S,8aS)-6-(4-hydroxyphenyl)-1,2-dioxo-3,4-diphenyl-8-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2,2,2-trifluoroethylsulfonyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[[(2R,3R)-8-(3-cyclopentylprop-1-ynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2S,3S)-8-(3-cyclopentylprop-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2R,3R)-8-(3-cyclopentylprop-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2S,3R)-8-(3-cyclopentylprop-1-ynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2S,3S)-8-(3-cyclopentylprop-1-ynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
alpha-L-Fucp-(1->3)-[beta-D-Galp4F-(1->4)]-beta-D-GlcpNAc-OMe
N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-galactosyl-(1->3)-D-galactose
D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-D-manno-hexopyranose
D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-beta-D-manno-hexopyranose
D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->2)-alpha-D-manno-hexopyranose
2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
A linear amino trisaccharide comprising of 2-acetamido-2-deoxy-beta-D-glucopyranosyl residue (1->3)-linked to a beta-D-galactosyl residue, which is in turn linked (1->4) to D-glucose.